about
Effect of a Proton Pump Inhibitor on Tumor Bleeding Prevention in Unresectable Gastric Cancer Patients: a Double-Blind, Randomized, Placebo-Controlled TrialBotulinum Toxin Injection for the Treatment of Delayed Gastric Emptying Following Pylorus-Preserving Gastrectomy: an Initial Experience.Is the Reinitiation of Antiplatelet Agents Safe at 1 Week after Gastric Endoscopic Submucosal Dissection? Assessment of Bleeding Risk Using the Forrest Classification.Biopathologic features and clinical significance of micrometatasis in the lymph node of early gastric cancerImprovement of diabetes and hypertension after gastrectomy: a nationwide cohort study.Nomogram Incorporating CD44v6 and Clinicopathological Factors to Predict Lymph Node Metastasis for Early Gastric CancerTherapeutic Decision-Making Using Endoscopic Ultrasonography in Endoscopic Treatment of Early Gastric Cancer.Discrepancy between Clinical and Final Pathological Evaluation Findings in Early Gastric Cancer Patients Treated with Endoscopic Submucosal Dissection.Effect of Helicobacter pylori Eradication on Long-Term Survival after Distal Gastrectomy for Gastric Cancer.Phlegmonous Gastritis with Early Gastric Cancer.Endoscopic removal of a migrated coil after embolization of a splenic pseudoaneurysm: a case reportThe Effect of Endoscopic Resection on Short-Term Surgical Outcomes in Patients with Additional Laparoscopic Gastrectomy after Non-Curative Resection for Gastric Cancer.Increased RhoA Activity Predicts Worse Overall Survival in Patients Undergoing Surgical Resection for Lauren Diffuse-Type Gastric Adenocarcinoma.Practical intraoperative pathologic evaluation of sentinel lymph nodes during sentinel node navigation surgery in gastric cancer patients - Proposal of the pathologic protocol for the upcoming SENORITA trial.Optimal submucosal invasion of early gastric cancer for endoscopic resection.A randomised phase II study of continuous versus stop-and-go S-1 plus oxaliplatin following disease stabilisation in first-line chemotherapy in patients with metastatic gastric cancer.Effect of biopsy site on detection of gastric cancer high-risk groups by OLGA and OLGIM stages.Non-exposure simple suturing endoscopic full-thickness resection (NESS-EFTR) versus laparoscopic wedge resection: a randomized controlled trial in a porcine model.Characteristics of gastric cancer according to Helicobacter pylori infection status.Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer.Body mass index and mortality in patients with gastric cancer: a large cohort study.[A spongiform mass in the stomach: pyloric gland adenoma with a transition to adenocarcinoma].Role of Rac1 Pathway in Epithelial-to-Mesenchymal Transition and Cancer Stem-like Cell Phenotypes in Gastric Adenocarcinoma.Three-year interval for endoscopic screening may reduce the mortality in patients with gastric cancerThe distribution pattern of metastatic lymph nodes after non-curative endoscopic resection in early gastric cancer[Does surgical resection improve the survival in elderly patients with gastric cancer?]KMT2C Mutations in Diffuse-Type Gastric Adenocarcinoma Promote Epithelial-to-Mesenchymal TransitionEfficacy and Safety of Ghrelin Agonists in Patients with Diabetic Gastroparesis: A Systematic Review and Meta-AnalysisNationwide antibiotic resistance mapping of Helicobacter pylori in Korea: A prospective multicenter studyCDX1 Expression Induced by CagA-Expressing Helicobacter pylori Promotes Gastric TumorigenesisKRAS Activation in Gastric Adenocarcinoma Stimulates Epithelial-to-Mesenchymal Transition to Cancer Stem-Like Cells and Promotes Metastasis
P50
Q33849286-8FE7D09E-5B12-495A-894F-8062A8D221A3Q33849315-A063DE89-2C90-4B4E-AE70-2384C0F7FAE9Q33853172-217761B7-F558-4067-BA1D-C4CD5C4CF570Q34932726-CAF492BE-0498-464E-9CF1-20EB95AD8CB9Q35012062-5CA95AA7-71F3-48B6-A675-CBF3355BB64AQ36092350-4D2FE879-DC05-4878-BE1B-A2B98575509EQ36412873-86ACFB16-2E23-4BFC-9D3E-CF84303E6126Q36806689-E7146389-4343-42CA-BBF1-3012FDD87708Q37097513-59D70559-80BA-4C02-B943-FCFCDBA1E60DQ37342463-FBE1D552-F07A-4315-A453-1ADB9A273D84Q37714589-8F490289-627E-43BE-B564-853C334A11A7Q37717185-A27BF681-BC4B-4296-AE40-97218A4CC8C0Q38882545-BA9B7D21-3608-48DF-BB7F-5CCE49F39EAFQ38938318-9666B46D-3F1A-4908-9D45-CD9C41072BB2Q41552970-84D2D47E-202F-4312-BCD6-420CADBFFCE9Q47556122-5699A386-1FCC-4596-A869-4D6B229AD51BQ48302549-8E12D125-6908-4692-80F8-6A6599A753D1Q48366179-AA285333-F0D0-40EE-A845-E03EC704B685Q51146593-8BAD436D-DCD4-4509-A3B7-6062BE93EEA4Q52644829-057A24DB-805F-4396-A04A-9F20EE74D468Q53074070-15E63D07-1E25-4379-BB80-1B908287D3C4Q53282041-55DF4680-F5BD-4656-9127-13EB8A874BE1Q53320449-B7528684-9154-42B2-A95D-44577757876CQ57211237-B85CB0FD-A7C4-4010-8BCD-8CACBDB9AA2CQ58111633-FFD2D96C-BB43-4782-8C6C-61718BC59AC9Q84583230-E1B621FA-1216-4561-8599-28D7D35AB7E3Q90946268-E261D868-2ADB-4718-A898-BF3B59EE29FEQ91805832-A7904D97-4938-49CD-9C60-9D05D236FED1Q92181826-51358A94-0D6B-4661-A587-4362948CAC75Q92645973-678CCCA8-EE78-493F-8121-050CB1AC6D05Q92882784-9E1261E9-92DF-4AAA-BCB3-DE066F1F4FD0
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Soo Jeong Cho
@en
Soo Jeong Cho
@nl
type
label
Soo Jeong Cho
@en
Soo Jeong Cho
@nl
prefLabel
Soo Jeong Cho
@en
Soo Jeong Cho
@nl
P31
P496
0000-0001-7144-0589